Pemetrexed
Pemetrexed is an anti-cancer chemotherapy drug. It is classified as an antimetabolite. It is used in the treatment of malignant mesothelioma.
Primary Characteristics
Non-proprietary name: Pemetrexed.

Pharmacokinetics
None recorded.
Advertisement
Indications
Pemetrexed is primarily indicated in conditions like Mesothelioma, Non-small cell lung carcinoma.
Contraindications
Pemetrexed is contraindicated in conditions like Thrombocytopenia, Renal diseases, Pregnancy, Lactation.
Dosage
Pemetrexed's dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 500 mg/m2 | 500 mg/m2 | — | IV | Pemetrexed is given in the form of Pemetrexed disodium infused over 10 min on day 1 of each 21-day cycle. |
| Paediatric Dosage (20kg) | ||||
| No data. | ||||
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
Pemetrexed is known to cause more or less tolerable side effects which are usually transient. These include Anemia, Anorexia , Chest pain, Constipation , Depression, Fatigue, Fever, Increase in blood test creatinine, Leucopenia, Low platelet count, Mouth ulcers, Nausea and vomiting, Numbness , Tingling of the hand.
Warnings / Precautions
Interference in Pathology
Pemetrexed may interfere in the diagnosis of Elevation in ALT or AST.
Available Brands
Drug Classification
- 1.8.2 — Cytotoxic (anti-neoplastic) drugs